Abstract
In 2015, more than 530 000 people were prescribed statins in Norway. Adverse effects from the musculoskeletal system as well as less specific side effects are frequently reported. The extent of these contrasts with observations made in randomised controlled studies which report the prevalence of such adverse effects as being in line with placebo. Breaks from drug treatment, low doses, switching medication and use of other lipid-lowering drugs are the most relevant approaches to dealing with adverse effects.
| Translated title of the contribution | Statin intolerance |
|---|---|
| Original language | Other |
| Pages (from-to) | 36-38 |
| Number of pages | 3 |
| Journal | Tidsskrift for den Norske Laegeforening |
| Volume | 137 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2017 |
ASJC Scopus Subject Areas
- General Medicine
Keywords
- Biological Products/administration & dosage
- Muscular Diseases/chemically induced
- Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage
- Hypolipidemic Agents/administration & dosage
- Ezetimibe/administration & dosage
- Humans
- Risk Factors
- PCSK9 Inhibitors